baber/WOPTO huggingface dataset:
Patent NZ-525389-A (NZ)
Title: Methods of modulating apoptosis by administration of relaxin agonists or antagonists
Inventor: AMENTO EDWARD P
IPC: A61P15/08
Filed: 2001-10-04
Abstract: A relaxin agonist can be used in the production of a pharmaceutical composition for decreasing apoptosis in cells expressing a relaxin receptor in a subject having a condition associated with an abnormal rate of apoptosis. Preferably the cells are from the reproductive tract and the subject has a relaxin deficient conditions such as immature tissue, excessive collagen deposition, low sperm count or under developed testes. Also described is the use of a relaxin antagonist in the production of a pharmaceutical composition for increasing apoptosis in cells expressing in subjects having a condition associated with an abnormal rate of apoptosis. Preferably the condition is hyperplasia, hypertrophy, cancer, neoplasia
Patent NZ-531554-A (NZ)
Title: Non-removable device for attaching a dispenser to a container
Inventor: HUBMANN CURTIS H
IPC: B65D47/02
Filed: 2002-10-15
Abstract: A device for non-removably attaching a dispenser 2 to a container 21 is disclosed. A bracket member 6 has a closure portion 14 which engages the mouth 22 of the container. The closure portion is connected to the body of the dispenser member. A fastening member 3 engages the bracket 6 and the mouth 22 of the container. A further embodiment of the invention includes a locking member 7 which is both frictionally connected and welded to the container.
Patent NZ-535506-A (NZ)
Title: Distance extender and method making use of same
Inventor: VOLL PARKER J
IPC: H04B3/44
Filed: 2004-09-23
Abstract: A distance extender (100, 200) for increasing a distance between a first device (145) and a second device (150) in electrical communication with the first device includes an electrical cable (130, 230) electrically coupled between the first device and the second device, a first subsystem (110, 210) electrically coupled to the first end of the electrical cable, and a second subsystem (120, 220) electrically coupled to the second end of the electrical cable. The electrical cable includes a first end (131, 231), a second end (132, 232), and a plurality of wires extending between the first end and the second end. The plurality of wires includes a first wire, the first device generates a data signal and provides an electrical power signal, and the data signal and the electrical power signal are simultaneously transmitted between the first device and the second device over the first wire.
Patent NZ-536807-A (NZ)
Title: A customer rewards program
Inventor: BROEKHUIS GEOFF YACOB
Filed: 2004-11-25
Abstract: A customer rewards system or programme includes a provider selecting preferred businesses to be members of the system. The provider provides the members of the system with a plurality of identification means. Each identification means has at least one unique identifier and the members of the system provide an identification means to a holder at the discretion of the members. Each identification means is adapted to allow the holder to identify themselves to a system member to obtain a reward when a purchase is made from a system member. The provider also provides a website to provide communication of advantages and specific promotions regarding the system to the holders and provides a feedback means associated with the website where the holders can provide feedback to members of the system about the service provided by the members. The holders are required to use their unique identifier when providing feedback and feedback is encouraged through rewards. The provider analyses and collates the holder feedback obtained through the feedback means for useful information regarding the service provided to the holders and provides the useful information to the members of the system. Receiving the reward is not dependant upon the accumulation of reward value measuring indicia by the holder of the identification means.
Patent NZ-536897-A (NZ)
Title: Whey protein hydrolysate
Inventor: SORENSEN THOMAS LYKKE
IPC: A23C19/05
Filed: 2003-06-03
Abstract: Disclosed is a method for producing a whey protein hydrolysate comprising: a) Adding a metalloprotease to a composition comprising whey protein, and b) Heat treating said composition at a temperature of between 70 and 98 °C for a time sufficient to induce gelation of the composition. Also disclosed is a method for producing cheese comprising: a) Adding a metalloprotease to a composition comprising whey protein, b) Heat treating said composition at a temperature of between 70 and 98 °C for a time sufficient to induce gelation of the composition, and c) Adding said composition to cheese milk and producing cheese from the cheese milk.
Patent NZ-537226-A (NZ)
Title: Therapeutic epitopes and uses thereof for treating and preventing coeliac disease
Inventor: ANDERSON ROBERT PAUL
IPC: A61K38/00
Filed: 2003-06-05
Abstract: Disclosed is the use of at least one agent for a method of diagnosing or treating coeliac disease, where the agent is selected from: (a) a peptide comprising at least one epitope comprising a transglutaminase-deamidated QPQQXFP amino acid sequence wherein X = P, T or Q; and (b) an analogue of (a) which is capable of being recognised by a T cell receptor that recognises the epitope of (a) and which is not more than 50 amino acids in length; and (c) optionally, in addition to the agent selected from (a) and (b), a peptide comprising at least one epitope comprising a sequence selected from SEQ ID NO:1 and SEQ ID NO:2.
Patent NZ-538829-A (NZ)
Title: Device for analysing analyte compounds and use hereof
Inventor: CHEN FEI
IPC: G01N33/543
Filed: 2003-09-11
Abstract: An analytical device, in the form of a dry-stick, comprising a porous material that permits liquid material to migrate therein is provided. The device comprising in the migration direction: (i) a first zone onto which a sample suspected of containing an analyte to be assayed can be applied, (ii) a second zone incorporating a non-immobilised molecule capable of specifically binding to the analyte, said non-immobilised molecule is provided with a detectable label, (iii) a third zone capable of retarding the rate of migration of a sample and the non-immobilised molecule, and (iv) a fourth zone incorporating in at least part of the zone an immobilised state the same type of analyte as the one to be assayed or an analogue thereof being capable of specifically binding to the non-immobilised molecule.
Patent NZ-540431-A (NZ)
Title: Beverage pack
Inventor: JAMES STEPHEN ANDREW CRAIG
IPC: B31B50/00
Filed: 2005-05-27
Abstract: The beverage pack comprises a bladder with at least one strap that is integral to the pack. The pack is manufactured so that it is highly durable, strong and minimises plastic wastage, making the pack durable, cost effective and beneficial to the environment. In some forms the pack is be disposable. The pack preferably includes an area of insulation, such as bubble type wrap or any other appropriate insulating material, on at least part of it. The pack may also include a reflective panel, such as silver type plastic, on its front panel to keep the beverage within the pack cold and to reflect sunlight. The pack includes a non-toxic drinking hose that is sealed within pack. The integrated strap enables the pack to be easily manufactured to keep it durable and strong to be carried by a person and taken anywhere.
Patent NZ-540846-A (NZ)
Title: Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
Inventor: VANDECRUYS ROGER PETRUS GEREBE
IPC: A61K31/505
Filed: 2003-11-25
Abstract: Disclosed is a semi-solid or solid pharmaceutical composition comprising a basic or acidic drug compound, Vitamin E TPGS and a physiologically tolerable water-soluble acid/base wherein the acid/base:drug compound ratio is at least 1:1 weight. Also disclosed are pharmaceutical dosage forms comprising the composition and a process of preparation.
Patent NZ-542419-A (NZ)
Title: A wellbore apparatus and method for completion, production and injection where a number of fluid paths and screens are provided to prevent blockages
Inventor: DALE BRUCE A
IPC: E21B43/08
Filed: 2004-01-20
Abstract: A wellbore apparatus that includes a first conduit defining a first fluid flow path in a wellbore, a second conduit defining a second fluid flow path in the wellbore and at least one wall (43) inside the first flow path or the second flow path to form at least one compartment (47) in the first flow path or the second flow path. The first and second conduits have least one permeable surface that is adapted to retain particles larger than a predetermined size (42) while allowing fluids to pass through and at least one impermeable surface. The permeable sections of the first conduit surface are in fluid communication with permeable sections of the second conduit surface providing fluid communication between the first flow path and the second flow path. Regardless of individual flow paths becoming blocked (48), there remains at least one flow path (17) for fluid within the wellbore.
Patent NZ-544898-A (NZ)
Title: Marine propulsion system
Inventor: ROSENKRANZ HANS GUNTHER
IPC: B63H3/04
Filed: 2004-07-20
Abstract: A marine propulsion system with a push rod (50) for adjusting the pitch of propeller blades (34) is disclosed. A screw-threaded bolt (60) is arranged around the push rod (50) and is engaged with a nut (78). The bolt has a chamber (66) for receiving a thrust portion (54) of the push rod, so that on rotation of the nut in one direction the bolt is moved in a first direction and the push rod is moved with the bolt whilst being able to rotate within the bolt because of engagement of the thrust portion within the chamber. Upon rotation of the nut in the opposite direction the bolt and rod are moved in a second direction opposite the first direction because of engagement of the thrust portion of the rod in the chamber.
Patent NZ-547479-A (NZ)
Title: Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
Inventor: BONFANTI JEAN-FRANCOIS
IPC: A61K31/4184
Filed: 2004-12-20
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are antivirals, useful in the treatment of respiratory syncytial virus (RSV).
Patent NZ-547558-A (NZ)
Title: Compositions and methods for the treatment of tumor of hematopoietic origin
Inventor: CROWLEY CRAIG
IPC: A61K39/00
Filed: 2004-11-16
Abstract: Provided is the use of an antibody that specifically binds a protein having at least 80% amino acid sequence identity to a specified polypeptide sequence or a corresponding nucleotide sequence in the manufacture of a medicament for inhibiting unwanted cell growth or treating cancer wherein the medicament is formulated for contacting said cell with an antibody that binds to said protein thereby causing an inhibition of growth of said cell, wherein said antibody is conjugated to a growth inhibitory agent or cytotoxic agent.
Patent NZ-548129-A (NZ)
Title: Pharmaceutical preparation comprising an antibody against the EGF receptor
Inventor: MAHLER HANNS-CHRISTIAN
IPC: C07K16/28
Filed: 2004-10-26
Abstract: Disclosed is a stable, aqueous pharmaceutical preparation comprising an anti-epidermal growth factor receptor (EGFR) antibody, a buffer, an amino acid and a surfactant with the proviso, that it does not contain any sugar and its use for treating tumour diseases.
Patent NZ-548525-A (NZ)
Title: Microwave induced pyrolysis reactor and method using two chambers each with stirrers and microwave absorbing material
Inventor: LUDLOW-PALAFOX CARLOS
IPC: C10B53/00
Filed: 2004-12-22
Abstract: A continuous method and reactor for recycling a metal/organic laminate comprising metal such as aluminium, laminated with an organic material is disclosed. The method comprises the steps of: - Providing a reactor (1) comprising a first chamber (2) having a first rotary stirrer (4) and a second chamber (3) having a second rotary stirrer (5), each chamber (2, 3) containing a bed of particulate microwave absorbing material; - Introducing laminate and additional particulate microwave absorbing material into the first chamber (2) via an inlet (6); - Under a reducing or inert atmosphere stirring the mixture of particulate microwave absorbing material and laminate in the first chamber (2) using the first rotary stirrer (3) and applying microwave energy in the first chamber (2) to heat the particulate microwave absorbing material to a temperature sufficient to pyrolyse organic material in the laminate; - Transferring a portion of the mixture in the first chamber (2) to the second chamber (3); - Stirring the mixture in the second chamber (3) using the second rotary stirrer (5) and applying microwave energy in the second chamber (3) to heat the particulate microwave absorbing material to a temperature sufficient to pyrolyse organic material remaining in the laminate, whereby laminate or delaminated metal migrates towards and floats on the upper surface of the mixture in the second chamber (3), the second rotary stirrer (5) rotating in a horizontal plane and being so configured as to fluidise the mixture such that the upper surface of the fluidised mixture has a radial profile that biases laminate or delaminated metal floating on the fluidised mixture to migrate radially outwards; - Transferring a portion of the mixture in the second chamber (3) to an exit (7) from the reactor (1); and recovering metal from the exit (7).
Patent NZ-550814-A (NZ)
Title: A method for the prevention of thromboembolic disorders
Inventor: HAIKALA HEIMO
IPC: A61K31/50
Filed: 2005-05-12
Abstract: Disclosed is the use of levosimendan or (R)-N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]acetamide or any of their pharmaceutically acceptable salts in the manufacture of a medicament for the prevention of cerebral thrombotic, embolic and/or hemorrhagic disorders.
Patent NZ-554546-A (NZ)
Title: (Purine-9-yl)-2,3-dihydroxycyclopentyl derivatives for use as adenosine A-2A receptor agonists
Inventor: FAIRHURST ROBIN ALEC
IPC: A61K31/52
Filed: 2005-10-21
Abstract: Disclosed are purine compounds of formula I in free or salt form, wherein the substituents are as defined in the specification and their use as adenosine A2A receptor agonists for treating diseases such as inflammatory or obstructive airways.
Patent NZ-562772-A (NZ)
Title: Tricyclic spiro derivatives as CRTH2 modulators
Inventor: SCHWARZ MATTHIAS
IPC: A61P29/00
Filed: 2006-05-23
Abstract: Spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component, more particularly for the modulation of CRTH2 activity.
Patent NZ-565609-A (NZ)
Title: Fluid entrapment detection
Inventor: DARBY ADAM JOHN
Filed: 2008-01-31
Abstract: A washing machine includes a cabinet, a wash tub supported within the cabinet, a spin basket for holding a wash load, the spin basket rotatable in the wash tub by a motor, and a controller for driving the motor to rotate the spin basket. The controller is adapted to detect water entrapment within a wash load in a spin basket of a washing machine by measuring a first parameter indicative of the rotational inertia of the spin basket when accelerated to a first spin speed, controlling the spin basket to dewater a wash load in the spin basket, measuring a second parameter indicative of the rotational inertia of the spin basket at the first speed, comparing the first and second parameters, and detecting whether there is water entrapped in the wash load based on the comparison between the first and second parameters.
Patent NZ-574313-A (NZ)
Title: Antibacterial compositions
Inventor: HAYDON DAVID JOHN
IPC: A61K31/4406
Filed: 2007-06-21
Abstract: Disclosed are benzothiazole or pyridothiazole compounds, represented by general formula (I), or salts, hydrates, solvates or N-oxides thereof. Also disclosed is the use of the compound of general formula (I) in the preparation of an antibacterial composition. Methods of making the compounds of formula (I) are also disclosed.
Patent NZ-575969-A (NZ)
Title: Light delivery system
Inventor: BARNARD WILLIAM LOUIS
IPC: A61N5/06
Filed: 2007-10-11
Abstract: A device for performing a medical treatment and a method of manufacturing the device are disclosed. The device (110) comprises a plurality of light sources (120) capable of emitting light for treating a patient; a distal tip (114) having a substantially flat elongate support and being dimensioned for placement within a patient and an outer member surrounding and encapsulating the elongate support and the plurality of light sources. The support comprises a transmissive material such that a substantial portion of the light emitted from the plurality of light sources directed towards the support is transmitted through the support when the light sources are energized and the plurality of light sources are coupled to the support. .
Patent NZ-576867-A (NZ)
Title: Detecting incorrect positioning of a carrying cable in cableway by detecting the rotation of a shoe or guide in responce to the cable leaving the cableway
Inventor: LUGER PETER
IPC: B61B12/06
Filed: 2009-05-07
Abstract: An arrangement for detecting incorrect alignment of a cable on a cableway is disclosed. The arrangement comprises a mount (8) with a channel (3) in which the carrying cable is located, and a device (19) for detecting incorrect positioning of the carrying cable. A portion of the mount (7) defining the channel is movable, for example about an axis parallel with the channel axis thus enabling a rocking motion. The movement of the channel that would indicate an imminent misalignment is detected by the device (19), for example a sensor. The sensor may be electrical, electromagnetic or optical in nature.
Patent NZ-576929-A (NZ)
Title: Crystalline anhydrous form C of moxifloxacin hydrochloride
Inventor: PATHI SRINIVAS LAXMINARAYAN
IPC: A61K31/4709
Filed: 2007-11-13
Abstract: Disclosed is crystalline anhydrous form C of moxifloxacin hydrochloride characterised by having an XRPD with peaks at 10.24, 15.08, 17.21, 24.60, 25.06, 26.42, 27.86, 28.22, 28.88 and 29.85 ± 0.2 °2q, and which also exhibits a melting endotherm peak at 253°C as measured by differential scanning calorimetry (10.00 ºC/minute). Further disclosed is a method of making moxifloxacin hydrochloride form C as defined above which comprises dissolving or suspending moxifloxacin base in methanol; treating the solution with methanolic hydrochloric acid; isolating the resulting moxifloxacin hydrochloride; and drying said moxifloxacin hydrochloride under vacuum at 80 - 90°C to obtain Form C.
Patent NZ-583153-A (NZ)
Title: Anti-IL-12 antibodies, epitopes, compositions, methods and uses
Inventor: GILES-KOMAR JILL
IPC: A61K39/395
Filed: 2005-12-20
Abstract: Provided is a method for producing an isolated mammalian anti-IL-12 antibody from a non-human animal, wherein said antibody comprises at least two complementarity determining regions (CDRs), and wherein said antibody binds to a portion of the IL-12 protein corresponding to at least one amino acid residue selected from the group consisting of residues 15, 17-21,23,40-43,45-47,54-56 and 58-62 of a specified amino acid sequence, comprising panning an antibody library with a protein variant of the amino acid sequence comprising residues 15, 17-21,23,40-43,45-47,54-56 and 58-62 of the amino acid sequence, selecting an antibody that binds to at least one of said amino acid residues, and recovering said antibody from the non-human animal.
Patent NZ-584696-A (NZ)
Title: Plasma processing delivery system
Inventor: WOODCOCK MALCOLM
IPC: B05D7/24
Filed: 2008-09-25
Abstract: Disclosed is a delivery system (10) for delivering species to a processing chamber (14) for imparting a desired surface property to one or more large items. The invention comprises a first container (16) for filling with liquid species, a second container (18) for receiving liquid species from the first container, a first flow control means (20) for controlling a volume of liquid species which is allowed to flow from the first container to the second container. Evaporation means (30) for evaporating liquid species in the second container and a second flow control means (38) for controlling flow of evaporated species from the second container to a processing chamber.
Patent NZ-584969-A (NZ)
Title: Method for the heterogenically catalyzed esterification of fatty acids
Inventor: DIETRICH WULF
IPC: C07C69/52
Filed: 2008-10-16
Abstract: Disclosed is a process for reducing the content of free fatty acids in fats and/or oils characterized by the steps of reacting the free fatty acids in said fats and/or oils with alcohols at temperatures between 60 and 120 degrees Celsius using acidic, heterogeneous ion exchange resin catalysts, wherein said acidic, heterogeneous ion exchange resin catalysts are present in a continuous alcoholic phase in which said free fatty acids are present in finely dispersed form and wherein the reaction zone in which the foregoing reaction is performed is flowed through vertically from the top downward, and wherein a continuous alcoholic phase is present at the upper end of the reaction zone.
Patent NZ-587570-A (NZ)
Title: Process for producing spray dried particles with trapped gas phrase active ingredient that may be an aroma or flavouring compound for a food
Inventor: POORTINGA ALBERT THIJS
IPC: A23L27/00
Filed: 2009-02-25
Abstract: Discloses a process for preparing particles, which particles contain spaces in which a gas phase is present which comprises at least one active ingredient. The said spaces are surrounded by an enveloping phase which at ambient temperature is solid and impermeable to the active ingredient. The process comprises the steps of: (i) allowing the gaseous active ingredient to migrate from or through the enveloping phase into the space or spaces at a temperature at which the enveloping phase is permeable to the gaseous active ingredient; (ii) and then cooling the particles to a temperature at which the enveloping phase of the particles is at least substantially impermeable to the active ingredient in the particles The active ingredient is an aroma or volatile flavouring agent or precursor. The enveloping phase may be from a group of selected carbohydrate compounds or whole proteins. Further disclosed are specific conditions at which the process is carried out. Also discloses spray dried powder particles obtained according to the said process. The particles may form part of e.g. a food composition or personal care product.
Patent NZ-587580-A (NZ)
Title: Factor VII or VIIa Gla domain variants
Inventor: HAANING JESPER MORTENSEN
IPC: A61K38/36
Filed: 2004-06-18
Abstract: Provided is a conjugate comprising a Factor VII (FVIl) or Factor VIIa (FVlla) polypeptide variant having an amino acid sequence that differs in 1·15 amino acid residues relative to the amino acid sequence of human Factor VII (hFVII) or human Factor VIla (hFVIIa) shown in SEQ ID NO:I, wherein a negatively charged amino acid residue has been introduced by substitution in position 36 in the variant sequence, conjugated to a biocompatible polymer. The conjugates can be used to treat diseases in which inducing blood clot formation is beneficial, e.g. hemorrhage, variceal bleeding and hemophilia.
Patent NZ-591509-A (NZ)
Title: Taste masking of fluoroquinolones with a divalent or trivalent cation
Inventor: SURBER MARK W
IPC: A61K9/12
Filed: 2006-05-18
Abstract: Disclosed herein is a method of taste masking a fluoroquinolone, preferably one selected from the group of ciprofloxacin, gatifloxacin, gemifloxacin, norfloxacin, moxifloxacin, marbofloxacin, orbifloxacin, sparfloxacin, tosufloxacin, trovafloxacin, pefloxacin, lomefloxacin, clinafloxacin, prulifloxacin, sarafloxacin, sitafloxacin, and pazufloxacin; the method comprising combining the fluoroquinolone with an amount of a divalent or trivalent cation sufficient to mask the taste of the fluoroquinolone. Suitable cations include one or more of magnesium, calcium, aluminium, zinc, and iron.